首页> 外文OA文献 >Synthesis, characterization and antitumor activity of cis- bis(acylthioureato) platinum(II) complexes, cis-PtL2HL 1=N,N-diphenyl-N'-benzoylthiourea or HL2 = N,N-diphenyl-N'-(p-nitrobenzoyl)thiourea
【2h】

Synthesis, characterization and antitumor activity of cis- bis(acylthioureato) platinum(II) complexes, cis-PtL2HL 1=N,N-diphenyl-N'-benzoylthiourea or HL2 = N,N-diphenyl-N'-(p-nitrobenzoyl)thiourea

机译:顺式-双(酰基硫脲基)铂(II)配合物,顺式-PtL2 HL 1 = N,N-二苯基-N'-苯甲酰基硫脲或HL2 = N,N-二苯基-N'-的合成,表征和抗肿瘤活性(对硝基苯甲酰基)硫脲

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Acylthiourea ligands, N,N-diphenyl-N'-benzoylthiourea (HL 1) and N,N-diphenyl-N'-(p-nitrobenzoyl) thiourea (HL 2) were prepared in high yields (HL1: 90%, HL2: 82%), by converting benzoyl chloride or p-nitrobenzoyl chloride into the corresponding benzoyl isothiocyanate followed by reacting with diphenylamine. The cis-[PtL2] complexes have been synthesized by reaction of the ligands HL1 or HL2 with K2PtCl4 in a Pt:HL (1:2) molar ratio, in the presence of sodium acetate. The ligands and their cis-[PtL2] complexes have been characterized by elemental analysis, IR, FAB(+)-MS,1H-NMR, 13C-NMR and 195Pt-NMR. The molecular structure of cis-bis(N,N-diphenyl-N'- benzoylthioureato) platinum(II) shows a square-planar geometry with two deprotonated ligands (L1) coordinated to Pt(II) through the oxygen and sulfur atoms in a cis arrangement. The antitumor activity of the ligands and their cis-[PtL2] complexes was evaluated on mouse mammary adenocarcinoma TA3. The IC50 values of culture growth for ligands HL1 and HL2 were 23.1 and 34.9 µM, respectively, whereas for the cis-[PtL2] complexes they were in the range of 2.6-2.8 µM, which indicates that the platinum(II) complexes are about 10-fold more cytotoxic than the free ligands and a participation of nitro group in the complex activity is slightly relevant.
机译:制备高收率的酰基硫脲配体N,N-二苯基-N'-苯甲酰基硫脲(HL 1)和N,N-二苯基-N'-(对硝基苯甲酰基)硫脲(HL 2)(HL1:90%,HL2:通过将苯甲酰氯或对硝基苯甲酰氯转化为相应的苯甲酰基异硫氰酸酯,然后与二苯胺反应,得到82%)。在乙酸钠存在下,配体HL1或HL2与K2PtCl4以Pt:HL(1:2)摩尔比反应,合成了顺式[PtL2]配合物。通过元素分析,IR,FAB(+)-MS,1H-NMR,13C-NMR和195Pt-NMR对配体及其顺式[PtL2]配合物进行了表征。顺式-双(N,N-二苯基-N'-苯甲酰基硫脲基)铂(II)的分子结构显示出具有两个去质子化的配体(L1)通过氧原子和硫原子与Pt(II)配位的方平面几何结构顺式排列。在小鼠乳腺腺癌TA3上评估了配体及其顺式[PtL2]复合物的抗肿瘤活性。配体HL1和HL2的培养物生长的IC50值分别为23.1和34.9 µM,而对于顺式-[PtL2]配合物,其范围为2.6-2.8 µM,这表明铂(II)配合物约为细胞毒性比游离配体高10倍,硝基基团参与复杂的活性略有相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号